Vertex Pharmaceuticals Incorporated VRTX
549.04 USD +18.28 (+3.44%)
At closeNov 5, 2026, 4:39 AM EST
551.00 +1.96 +0.36%
Pre-market · Nov 5, 4:39 AM ET
527.38 Day range 550.77
406.67 52-week range 568.67
- YTD
- +21.10%
- 1 year
- +30.21%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 12.00B | 11.02B | 9.87B | 8.93B | 7.57B | |
| 10.35B | 9.49B | 8.61B | 7.85B | 6.67B | |
| 4.18B | -233.40M | 3.78B | 4.25B | 2.78B | |
| 3.95B | -535.60M | 3.62B | 3.32B | 2.34B | |
| 15.32 | -2.08 | 13.89 | 12.82 | 9.01 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 5.08B | 4.57B | 10.37B | 10.50B | 6.79B | |
| 25.64B | 22.53B | 22.73B | 18.15B | 13.43B | |
| 6.98B | 6.12B | 5.15B | 4.24B | 3.33B | |
| 1.85B | 1.54B | 724.70M | 810.30M | 887.20M | |
| 18.67B | 16.41B | 17.58B | 13.91B | 10.10B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.63B | -492.60M | 3.54B | 4.13B | 2.64B | |
| -945.40M | -3.77B | -3.14B | -321.10M | -340.90M | |
| -2.26B | -1.49B | -562.20M | -67.70M | -1.48B | |
| -437.60M | -297.70M | -200.40M | -204.70M | -235.00M | |
| 515.60M | -5.80B | -139.70M | 3.71B | 811.20M |